Chemical and Pharmaceutical Bulletin · 2004 · 38 citations · 52 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignPharmacophore ModelingStructure-activity RelationshipsCytochrome P450 EnzymesCytochrome P450 InteractionsCytochrome P450-mediated MetabolismLigand BindingMolecular DockingProtein-ligand DockingActive Site AnalysisActive Site CharacterizationCytochrome P450 3A4 MetabolismCytochrome P450 Active Site ArchitectureCytochrome P450 Enzyme ActivityCytochrome P450 Ligand BindingCytochrome P450 ModelingHomology
Human microsomal cytochrome P450s participate in drug metabolism and detoxification. Among them, CYP3A4 is the most important isoform for drug-drug interactions. To gain a better understanding of the active site, a homology model of CYP3A4 was constructed based on the crystallographic coordinates of mammalian CYP2C5. The putative active site is much larger than that of CYP2C5 and is divided into three parts (i.e. a proximal and two distal sites from the heme). Most residues reported to be important for ligand-binding are located in the active site of the model. Moreover, some inhibitors (paclitaxel etc.) docked into the model have complementary shapes to the pocket. Pharmacophore docking of 14 substrates was also performed using Ph4Dock of MOE. Calculated interaction energies showed a moderate correlation with the logarithm of apparent K(m) values. These results suggest that this model is reliable enough to be used in the design of compounds for removing undesirable CYP3A4 inhibition.
52
Julie Thompson, Desmond G. Higgins, Toby J. Gibson · Nucleic Acids Research · 1994 · 64.9K citations · Full text
Tsutomu Shimada, Hiroshi Yamazaki, Mayumi Mimura et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 2.8K citations
Medicine, Biochemistry, Pharmacology +15